Recurrent CIC gene abnormalities in angiosarcomas: A molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations

Shih Chiang Huang, Lei Zhang, Yun Shao Sung, Chun Liang Chen, Yu-Chien Kao, Narasimhan P. Agaram, Samuel Singer, William D. Tap, Sandra D'Angelo, Cristina R. Antonescu

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Angiosarcoma (AS) is a rare sarcoma subtype showing considerable clinicopathologic and genetic heterogeneity. Most radiation-induced AS show MYC gene amplifications, with a subset of cases harboring KDR, PTPRB, and PLCG1 mutations. Despite recent advances, the genetic abnormalities of most primary AS remain undefined. Whole-transcriptome sequencing was initiated in 2 index cases of primary soft tissue AS with epithelioid morphology occurring in young adults for novel gene discovery. The candidate abnormalities were validated and then screened by targeted sequencing and fluorescence in situ hybridization in a large cohort of 120 well-characterized AS cases. Findings were subsequently correlated with the status of KDR, PLCG1, MYC, and FLT4 gene abnormalities. The clinicopathologic relevance and prognostic significance of these genetic changes were analyzed by statistical methods. Concurrent CIC mutations and CIC rearrangements were identified in both index cases, with a CIC-LEUTX fusion detected in 1 case. Upon screening, an additional visceral AS in a young adult had a complex CIC rearrangement, whereas 6 others harbored only CIC mutations. All 3 CIC-rearranged AS cases lacked vasoformation and had a solid growth of round, epithelioid to rhabdoid cells, showing immunoreactivity for CD31 and Etsrelated gene and sharing a transcriptional signature with other round cell sarcomas, including CIC-rearranged tumors. Overall, CIC abnormalities occurred in 9% (9/98) of cases, affecting younger patients with primary AS, with an inferior disease-free survival. In contrast, PLCG1 and KDR mutations occurred in both primary and secondary AS cases, accounting for 9.5% and 7%, respectively, with a predilection for breast and bone/viscera location, regardless of MYC status. MYC amplification was present in most secondary AS related to breast cancer (91%) compared with other causes (25%) or primary AS (7%). FLT4-amplified AS lacked PLCG1/KDR mutations, occurring predominantly in MYC-amplified population, and showed poor prognosis.

Original languageEnglish
Pages (from-to)645-655
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume40
Issue number5
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Hemangiosarcoma
Genes
Mutation
Sarcoma
Young Adult
Genetic Heterogeneity
Viscera
Gene Amplification
Genetic Association Studies
Fluorescence In Situ Hybridization
Transcriptome
Disease-Free Survival
Breast

Keywords

  • Angiosarcoma
  • CIC
  • FLT4
  • KDR
  • MYC
  • PLCG1

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

Recurrent CIC gene abnormalities in angiosarcomas : A molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations. / Huang, Shih Chiang; Zhang, Lei; Sung, Yun Shao; Chen, Chun Liang; Kao, Yu-Chien; Agaram, Narasimhan P.; Singer, Samuel; Tap, William D.; D'Angelo, Sandra; Antonescu, Cristina R.

In: American Journal of Surgical Pathology, Vol. 40, No. 5, 01.01.2016, p. 645-655.

Research output: Contribution to journalArticle

Huang, Shih Chiang ; Zhang, Lei ; Sung, Yun Shao ; Chen, Chun Liang ; Kao, Yu-Chien ; Agaram, Narasimhan P. ; Singer, Samuel ; Tap, William D. ; D'Angelo, Sandra ; Antonescu, Cristina R. / Recurrent CIC gene abnormalities in angiosarcomas : A molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations. In: American Journal of Surgical Pathology. 2016 ; Vol. 40, No. 5. pp. 645-655.
@article{a09a4af5758845f28118ebe3bf7f2d08,
title = "Recurrent CIC gene abnormalities in angiosarcomas: A molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations",
abstract = "Angiosarcoma (AS) is a rare sarcoma subtype showing considerable clinicopathologic and genetic heterogeneity. Most radiation-induced AS show MYC gene amplifications, with a subset of cases harboring KDR, PTPRB, and PLCG1 mutations. Despite recent advances, the genetic abnormalities of most primary AS remain undefined. Whole-transcriptome sequencing was initiated in 2 index cases of primary soft tissue AS with epithelioid morphology occurring in young adults for novel gene discovery. The candidate abnormalities were validated and then screened by targeted sequencing and fluorescence in situ hybridization in a large cohort of 120 well-characterized AS cases. Findings were subsequently correlated with the status of KDR, PLCG1, MYC, and FLT4 gene abnormalities. The clinicopathologic relevance and prognostic significance of these genetic changes were analyzed by statistical methods. Concurrent CIC mutations and CIC rearrangements were identified in both index cases, with a CIC-LEUTX fusion detected in 1 case. Upon screening, an additional visceral AS in a young adult had a complex CIC rearrangement, whereas 6 others harbored only CIC mutations. All 3 CIC-rearranged AS cases lacked vasoformation and had a solid growth of round, epithelioid to rhabdoid cells, showing immunoreactivity for CD31 and Etsrelated gene and sharing a transcriptional signature with other round cell sarcomas, including CIC-rearranged tumors. Overall, CIC abnormalities occurred in 9{\%} (9/98) of cases, affecting younger patients with primary AS, with an inferior disease-free survival. In contrast, PLCG1 and KDR mutations occurred in both primary and secondary AS cases, accounting for 9.5{\%} and 7{\%}, respectively, with a predilection for breast and bone/viscera location, regardless of MYC status. MYC amplification was present in most secondary AS related to breast cancer (91{\%}) compared with other causes (25{\%}) or primary AS (7{\%}). FLT4-amplified AS lacked PLCG1/KDR mutations, occurring predominantly in MYC-amplified population, and showed poor prognosis.",
keywords = "Angiosarcoma, CIC, FLT4, KDR, MYC, PLCG1",
author = "Huang, {Shih Chiang} and Lei Zhang and Sung, {Yun Shao} and Chen, {Chun Liang} and Yu-Chien Kao and Agaram, {Narasimhan P.} and Samuel Singer and Tap, {William D.} and Sandra D'Angelo and Antonescu, {Cristina R.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/PAS.0000000000000582",
language = "English",
volume = "40",
pages = "645--655",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Recurrent CIC gene abnormalities in angiosarcomas

T2 - A molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations

AU - Huang, Shih Chiang

AU - Zhang, Lei

AU - Sung, Yun Shao

AU - Chen, Chun Liang

AU - Kao, Yu-Chien

AU - Agaram, Narasimhan P.

AU - Singer, Samuel

AU - Tap, William D.

AU - D'Angelo, Sandra

AU - Antonescu, Cristina R.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Angiosarcoma (AS) is a rare sarcoma subtype showing considerable clinicopathologic and genetic heterogeneity. Most radiation-induced AS show MYC gene amplifications, with a subset of cases harboring KDR, PTPRB, and PLCG1 mutations. Despite recent advances, the genetic abnormalities of most primary AS remain undefined. Whole-transcriptome sequencing was initiated in 2 index cases of primary soft tissue AS with epithelioid morphology occurring in young adults for novel gene discovery. The candidate abnormalities were validated and then screened by targeted sequencing and fluorescence in situ hybridization in a large cohort of 120 well-characterized AS cases. Findings were subsequently correlated with the status of KDR, PLCG1, MYC, and FLT4 gene abnormalities. The clinicopathologic relevance and prognostic significance of these genetic changes were analyzed by statistical methods. Concurrent CIC mutations and CIC rearrangements were identified in both index cases, with a CIC-LEUTX fusion detected in 1 case. Upon screening, an additional visceral AS in a young adult had a complex CIC rearrangement, whereas 6 others harbored only CIC mutations. All 3 CIC-rearranged AS cases lacked vasoformation and had a solid growth of round, epithelioid to rhabdoid cells, showing immunoreactivity for CD31 and Etsrelated gene and sharing a transcriptional signature with other round cell sarcomas, including CIC-rearranged tumors. Overall, CIC abnormalities occurred in 9% (9/98) of cases, affecting younger patients with primary AS, with an inferior disease-free survival. In contrast, PLCG1 and KDR mutations occurred in both primary and secondary AS cases, accounting for 9.5% and 7%, respectively, with a predilection for breast and bone/viscera location, regardless of MYC status. MYC amplification was present in most secondary AS related to breast cancer (91%) compared with other causes (25%) or primary AS (7%). FLT4-amplified AS lacked PLCG1/KDR mutations, occurring predominantly in MYC-amplified population, and showed poor prognosis.

AB - Angiosarcoma (AS) is a rare sarcoma subtype showing considerable clinicopathologic and genetic heterogeneity. Most radiation-induced AS show MYC gene amplifications, with a subset of cases harboring KDR, PTPRB, and PLCG1 mutations. Despite recent advances, the genetic abnormalities of most primary AS remain undefined. Whole-transcriptome sequencing was initiated in 2 index cases of primary soft tissue AS with epithelioid morphology occurring in young adults for novel gene discovery. The candidate abnormalities were validated and then screened by targeted sequencing and fluorescence in situ hybridization in a large cohort of 120 well-characterized AS cases. Findings were subsequently correlated with the status of KDR, PLCG1, MYC, and FLT4 gene abnormalities. The clinicopathologic relevance and prognostic significance of these genetic changes were analyzed by statistical methods. Concurrent CIC mutations and CIC rearrangements were identified in both index cases, with a CIC-LEUTX fusion detected in 1 case. Upon screening, an additional visceral AS in a young adult had a complex CIC rearrangement, whereas 6 others harbored only CIC mutations. All 3 CIC-rearranged AS cases lacked vasoformation and had a solid growth of round, epithelioid to rhabdoid cells, showing immunoreactivity for CD31 and Etsrelated gene and sharing a transcriptional signature with other round cell sarcomas, including CIC-rearranged tumors. Overall, CIC abnormalities occurred in 9% (9/98) of cases, affecting younger patients with primary AS, with an inferior disease-free survival. In contrast, PLCG1 and KDR mutations occurred in both primary and secondary AS cases, accounting for 9.5% and 7%, respectively, with a predilection for breast and bone/viscera location, regardless of MYC status. MYC amplification was present in most secondary AS related to breast cancer (91%) compared with other causes (25%) or primary AS (7%). FLT4-amplified AS lacked PLCG1/KDR mutations, occurring predominantly in MYC-amplified population, and showed poor prognosis.

KW - Angiosarcoma

KW - CIC

KW - FLT4

KW - KDR

KW - MYC

KW - PLCG1

UR - http://www.scopus.com/inward/record.url?scp=84953227690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953227690&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000582

DO - 10.1097/PAS.0000000000000582

M3 - Article

C2 - 26735859

AN - SCOPUS:84953227690

VL - 40

SP - 645

EP - 655

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 5

ER -